NASDAQ · SERVICES-HEALTH SERVICES · LARGE CAP
GeneDx Holdings Corp. WGS
7 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$427.5M
▲ 40.0% vs FY2024
EPS · FY25
$-0.73
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-7.6%
Net margin · FY25
-4.9%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 427.5M
Revenue, FY2025 · full 7-year series below
Revenue
Net income
The company lost 5 cents on every revenue dollar this year.
Per share
USD -0.73
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-7.6%
Return on equity, FY2025
ROE
Operating margin-3.1%
Net margin-4.9%
Return on assets-4.5%
Each USD of equity lost 8 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+19.0% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+22.1%
+19.0%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.03B
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 523.7M
total assets, end of FY2025
Total assetsUSD 523.7M
EquityUSD 308.2M
CashUSD 105.0M
Gross debtUSD 52.7M
Net debtUSD -52.3M
Current ratio2.46×
The company holds more cash than debt.
History
7 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
Revenue $B
0.4
0.3
0.2
0.2
0.2
0.2
0.2
Operating income $B
−0.0
−0.0
−0.2
−0.7
−0.4
−0.2
−0.0
EBITDA $B
−0.0
−0.0
−0.2
−0.6
−0.4
−0.2
−0.0
Income tax $B
−0.0
−0.0
−0.0
−0.0
0.0
0.0
0.0
Net income $B
−0.0
−0.1
−0.2
−0.5
−0.2
−0.2
−0.0
EPS, diluted $
−0.73
−1.94
−7.23
−53.63
−2.27
−47036.00
−264056.00
Dividend / sh $
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
ROE %
−7.6
−22.1
−73.0
−171.1
−845.4
·
·
Shares out B
0.03
0.03
0.03
0.01
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
26 of 26
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed